Answers are grounded in this paper and cite their sources.
Mangrove ecosystems are unique intertidal and coastal wetlands found in tropical and subtropical regions, serving as habitats for diverse marine and terrestrial organisms. Among these, mangrove-associated algae represent a valuable bioresource, producing a wide range of bioactive metabolites, including polysaccharides, pigments, carotenoids, phenolic compounds, lipids, alkaloids, flavonoids, glycosides, terpenoids, phenazines, and phycobiliproteins. These bioactive compounds can be produced under controlled laboratory conditions using open- or closed-culture systems, which are often optimized for specific growth phases. Metabolites derived from mangrove-associated algae exhibit diverse biomedical properties, such as antimicrobial, antiparasitic, antioxidant, anticancer, anti-diabetic, neuroprotective, and anti-inflammatory activities. Owing to these therapeutic potentials, mangrove-associated algae are considered promising candidates for the development of novel treatments for various diseases. This review explores the bioprospecting potential of secondary metabolites extracted from mangrove-associated algae, emphasizing their bioactivities and possible applications in biomedical research.
No takes yet. Share an insight, caveat, or question.
Pattapulavar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: